All bills
SB 1200 Referred

SB 1200 - Currently, a health care provider shall not knowingly prescribe or administer cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for children. This provision of law does not apply to those children who were prescribed or administered such drugs prior to August 28, 2023. This prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on August 28, 2027. This act removes that expiration date. Additionally, the provision excluding those children already prescribed or administered the hormones or drugs prior to August 28, 2023, from the general prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on March 1, 2027. This act is substantially similar to SB 75 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 249 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024). SARAH HASKINS

Official Bill Page

Loading official bill page…

Legislative Timeline

3 actions
  1. Jan 27, 2026 upper
    Second Read and Referred S Families, Seniors and Health Committee
  2. Jan 7, 2026 upper
    S First Read
  3. Dec 1, 2025 upper
    Prefiled
About this civic dataset

About this legislation view

Track federal and state bills and legislation — browse by chamber, status, and day, with summaries and sponsor details, updated daily on Civic Stream.

Use the scope, chamber, status, and search controls to move from the national legislation picture down to an exact state or legislative stage.